Supplementary table 5 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
<p>Supplementary table 5</p>
Na minha lista:
| Autor principal: | Wei Chen (15053713) (author) |
|---|---|
| Outros Autores: | Hui Shi (15053716) (author), Zhuojun Liu (15053719) (author), Fan Yang (15053722) (author), Jia Liu (15053725) (author), Leqiang Zhang (15053728) (author), Yajin Wu (15053731) (author), Yuanshi Xia (15053734) (author), Yuxuan Ou (15053737) (author), Ruiting Li (15053740) (author), Ting Zhang (15053743) (author), Jiecheng Zhang (15053746) (author), Xiaoyan Ke (15053749) (author), Kai Hu (15053752) (author), Jian Yu (11031782) (author) |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Supplementary table 6 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
por: Wei Chen (15053713)
Publicado em: (2025) -
Supplementary table 7 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
por: Wei Chen (15053713)
Publicado em: (2025) -
Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
por: Ibrahim Aldoss (15055961)
Publicado em: (2025) -
Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
por: Ibrahim Aldoss (15055961)
Publicado em: (2025) -
Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
por: Ibrahim Aldoss (15055961)
Publicado em: (2025)